Related Topics

2023 JUN   21
2022 DEC   2
mRNA Vaccine
2022 FEB   9
Corbevax and Covovax
2021 DEC   31
ACE 2 Proteins
2021 DEC   7
2021 NOV   27


2021 NOV 29

Preliminary   > Disaster Management   >   Disasters   >   COVID 19

Why in news?

  • An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's application seeking emergency authorisation of COVID-19 vaccine Covovax, has sought additional data from the firm, while noting the jab has not yet been approved in the country of origin.

About Covovax:

  • Covovax is the brand name of Novovax, a US-based biotechnology company’s COVID-19 vaccine candidate – officially known as NVX-Cov-2373.
  • In India, SII has received this licence to manufacture and distribute the vaccine.
  • The Serum Institute of India (SII) had put in an application to the Drugs Controller General of India (DCGI) in October,2021 for grant of market authorisation of Covovax for restricted use in emergency situation.
  • Covovax is more stable and easily stored than mRNA vaccines, which will be helpful in broad distribution.


Consider the following statements:

1. COVOVAX is India's indigenous COVID-19 vaccine

2. COVISHIELD is a viral vector vaccine

3. COVAXIN is developed using Whole-Virion Inactivated Vero Cell derived platform technology

Which of the statements given above is/are correct?

(a) 1 and 2 only

(b) 2 and 3 only

(c) 3 only

(d) 1,2 and 3